These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 34860880)

  • 21. Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial.
    Jha MK; Minhajuddin A; Gadad BS; Chin Fatt C; Trivedi MH
    Pharmaceuticals (Basel); 2019 Dec; 12(4):. PubMed ID: 31861074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dystonic rabbit syndrome from citalopram.
    Parvin MM; Swartz CM
    Clin Neuropharmacol; 2005; 28(6):289-91. PubMed ID: 16340386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bupropion and Escitalopram During Lactation.
    Neuman G; Colantonio D; Delaney S; Szynkaruk M; Ito S
    Ann Pharmacother; 2014 Jul; 48(7):928-931. PubMed ID: 24732787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
    Tseng PT; Lee Y; Lin YE; Lin PY
    Gen Hosp Psychiatry; 2012; 34(2):210.e13-5. PubMed ID: 22133983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
    Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G;
    JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escitalopram-induced severe akathisia leading to suicide attempt.
    Pratap A; Akhtar S; Sinha P; Bakhla AK
    Ind Psychiatry J; 2019; 28(2):315-317. PubMed ID: 33223729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modafinil therapy for apathy in an elderly patient.
    Padala PR; Burke WJ; Bhatia SC
    Ann Pharmacother; 2007 Feb; 41(2):346-9. PubMed ID: 17264158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy.
    Mencacci C; Di Sciascio G; Katz P; Ripellino C
    Clinicoecon Outcomes Res; 2013; 5():87-99. PubMed ID: 23413176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escitalopram: a second-generation SSRI.
    Owens MJ; Rosenbaum JF
    CNS Spectr; 2002 Apr; 7(4 Suppl 1):34-9. PubMed ID: 15131491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Escitalopram: a review of its use in the management of major depressive disorder.
    Murdoch D; Keam SJ
    Drugs; 2005; 65(16):2379-404. PubMed ID: 16266205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.
    Celada P; Bortolozzi A; Artigas F
    CNS Drugs; 2013 Sep; 27(9):703-16. PubMed ID: 23757185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal Uterine Bleed in a Postmenopausal Woman With the Use of Escitalopram.
    Yadav A; Bharat BS; Montrose S
    Cureus; 2022 Mar; 14(3):e23432. PubMed ID: 35475053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feeling blue to seeing red: A case of escitalopram-induced epistaxis.
    Ogundare T; Ologun OA
    Clin Case Rep; 2024 Jul; 12(7):e9128. PubMed ID: 38983874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case report: Escitalopram-associated lower limb edema.
    Ahmed MH; Al-Kubaisi M; Al-Rawi SA; Salama OH; Abutayyem HM
    Front Psychiatry; 2024; 15():1394813. PubMed ID: 38736624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical extrapyramidal manifestation of a typical antipsychotic with serotonergic antidepressant.
    Singh R; Chakrabarti SS; Kaur U
    Daru; 2024 Jun; 32(1):439-441. PubMed ID: 37962835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabbit Syndrome Likely Induced by Escitalopram: A Case Report.
    Nimber JS; Aggarwal A
    J Pharm Technol; 2014 Oct; 30(5):179-181. PubMed ID: 34860880
    [No Abstract]   [Full Text] [Related]  

  • 40. Escitalopram-induced Parkinsonism.
    Ak S; Anıl Yağcıoğlu AE
    Gen Hosp Psychiatry; 2014; 36(1):126.e1-2. PubMed ID: 24176515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.